Trials / Active Not Recruiting
Active Not RecruitingNCT05784883
Tricuspid Regurgitation in the ElderlY
Prevalence, Mechanisms, and Outcome of Tricuspid Valve Regurgitation in the Elderly
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 700 (actual)
- Sponsor
- Al-Azhar University · Academic / Other
- Sex
- All
- Age
- 60 Years
- Healthy volunteers
- Not accepted
Summary
Tricuspid regurgitation (TR) is the second most common VHD after MR. Its prevalence also increases with age, with an estimated incidence of up to 6% in elderly population. When adjusted to age (among other confounders), survival is worse for patients with moderate and severe TR. We aim to explore the prevalence, mechanisms, and clinical implications of tricuspid valve regurgitation in elderly subjects screened at a tertiary center in Cairo, Egypt.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Echocardiography | A comprehensive 2- and 3-dimensional transthoracic echocardiography (TTE) assessment of the tricuspid valve and right side of the heart at baseline. |
Timeline
- Start date
- 2022-08-01
- Primary completion
- 2024-03-01
- Completion
- 2029-08-01
- First posted
- 2023-03-27
- Last updated
- 2025-02-19
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05784883. Inclusion in this directory is not an endorsement.